08 June 2001
The Role of ERCP in Management of Biliary Complications after Liver Transplantation
J Spicak, M Ryska, P Trunecka, I Skala, P Stirand, F Belina, J Sperl, H Hrncarkova, P Taimr, S Vitko, K FilipAnn Transplant 2001; 6(2): 29-32 :: ID: 498322
Abstract
Biliary complications remain to pose a serious problem in patients after liver transplantation.. In the past,they occurred in asmany as 50% of patients,and were associated with a hight mortality. This haschanged and at present the incidence of this complications is lower. The authors present their own seriesand discuss the role of ERCP in the managmentof complications.
Keywords: Liver Transplantation, biliary complication, ERCP
In Press
Original article
Four Years of Clinical Experience With COVID-19 Outcomes in Heart Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952888
Original article
Determinants of Lack of Consent for Deceased Organ Donation Among Nurses and Physicians: A Cross-Sectional ...Ann Transplant In Press; DOI: 10.12659/AOT.953598
Original article
Influence of Pretransplant and Posttransplant Diabetes on Long-Term Heart Transplant OutcomesAnn Transplant In Press; DOI: 10.12659/AOT.953220
Original article
Learning Curve and Outcomes of Pure Laparoscopic Donor Major Hepatectomy Performed by Fellowship-Trained Su...Ann Transplant In Press; DOI: 10.12659/AOT.953061
Most Viewed Current Articles
24 Aug 2021 : Review article 21,439
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 17,693
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,494
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,401
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604